Lancet Global Health

Article	Citations
Correction to Lancet Glob Health 2021; 9: e1679–87	1124
Global health research funding applications: brain drain under another name?	496
Bringing home manufacturing of medical products	433
Preventing pellagra during isoniazid preventive treatment	386
Racism and health: the need for urgent action	366
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)	364
The future of the International Health Regulations	336
Influenza vaccination in failing hearts	330
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply	325
The cause of nodding syndrome remains unknown	312
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6	296
The drug drought in maternal health: an ongoing predicament	267
The pneumonia challenge: time to end the global neglect	227
Is now the time for revisiting supplements for pregnant women?	225
The road to malaria elimination: why a robust surveillance system is imperative	208
Expanding access to long-acting HIV therapy in low-income and middle-income countries	200
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study	184
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m	179
Challenges in operationalising clinical trials in India during the COVID-19 pandemic	179
Outcomes of rheumatic fever in Uganda: a prospective cohort study	179
The health status of Indonesia's provinces: the double burden of diseases and inequality gap	176
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou	168
Global and regional sepsis and infectious syndrome mortality in 2019: a systematic analysis	167
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study	165
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study	160

Mpox vaccination strategies in DR Congo	157
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study	156
C-reactive protein: another addition to our armamentarium against tuberculosis?	152
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor	150
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications	149
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr	142
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis	140
Resolving the CD4-testing crisis to help end AIDS-related deaths	130
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial	123
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis	120
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial	119
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study	119
Indonesia's first nationwide health screening programme	115
Global patterns and trends in Kaposi sarcoma incidence: a population-based study	115
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study	113
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys	113
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study	113
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019	109
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:	104
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement	104
Correction to Lancet Glob Health 2025; 13: e2013–26	102
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis	100
Payment in arrears: a global health inequity that must be corrected	100
Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995–2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023	98
Understanding deaths from diarrhoea in children younger than 5 years	97
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control	96
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition	95
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security	93
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden	93
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research	93
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine	91
Improving access to liposomal amphotericin B worldwide	89
Correction to Lancet Glob Health 2023; 11: e1978–85	88
Experiences of an Israeli hospital in the management of repatriated civilian hostages	88
Lessons for future implementation of the E-MOTIVE bundle	88
Bridging the gap between science and policy in global health governance	87
The social determinants of tuberculosis in the Philippines	86
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study	86
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned	85
Using theory to understand how interventions work and inform future implementation	81
Complementary medicine as a risk factor for catastrophic expenditures in people with cancer	81
Correction to Lancet Glob Health 2015; 3: e196	78
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study	77
Routine immunisation coverage in the context of seasonal influenza vaccine introduction for children in Nakuru and Mombasa counties in Kenya, 2019–21: an observational study	76
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all	76
Changes in incidence of HPV-related cancers in South Africa (2011–21): a cross-sectional analysis of the South African National Cancer Registry	76
How to DREAMM and end HIV-related deaths	74
Mpox: evidence for strengthening and sustaining global surveillance	74
Pregnancy in people who have survived Ebola virus disease	74
Addressing the complex needs of people with severe mental health disorders in low-resource settings	70

Commitment and innovation on the road to people-centred PHC financing	70
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply	68
Addressing the social inequities of vaccination: an imperative to close the gap	68
Correction to Lancet Glob Health 2022; 10: e1443–52	68
Next generation economics of universal HIV treatment	67
Cholera rapid diagnostic tests recycled for PCR confirmation	67
From child institutions to family reunification: challenges and opportunities in building family-centred care	66
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial	64
Cervical cancer elimination: actions needed in the COVID-19 era	63
Uncertainty in key population size estimates in sub-Saharan Africa	62
Climate change and health: the next challenge of ethical AI	61
Highlighting the need for investment and innovation in ART retention interventions	60
Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?	60
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026	60
Infertility—why the silence?	58
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns	57
Using verbal autopsy to enhance mortality surveillance	57
Child, maternal, and adult mortality in Sierra Leone: nationally representative mortality survey 2018–20	56
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation	55
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review	55
Characterisation of febrile non-traumatic coma in sub-Saharan Africa	54
Reducing antibiotic use with diarrhoeal vaccines	53
Every baby counts: eliminating all preventable child deaths	53
Precision in prescription: multiple micronutrient supplements in pregnancy	53
People who inject drugs in the Eastern Mediterranean region	53
Low risk, high impact: the hidden burden of cardiovascular disease	53
Migrants and displaced people: intentionally endangered and inconsistently visible	52
Lots of considerations when evaluating the FujiLAM assay – Author's reply	50
Correction to Lancet Glob Health 2022; 10: e1115–27	50
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation	49
Addressing global micronutrient inadequacies: enhancing global data representation	49
Withholding liberty, not the right to health	49
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings	48
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le	48
Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health	47
Pulse oximetry to detect paediatric hypoxaemia—the fifth vital sign	47
AI for health or AI for war? Challenging the military partnerships behind climate harm	47
COVID-19 in pregnancy: evidence from LMICs	46
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipaliti	46
Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis	46
Identifying gaps in the HIV treatment cascade in Africa: a model comparison study	45
Advancing functional and systemic integration of HIV prevention into public health systems	45
Reciprocal innovation: a new approach to equitable and mutually beneficial global health research and partnerships	45
Maternal intimate partner violence and child health outcomes	45
A home away from home? HIV outcomes among refugees and host country nationals	44
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) regi	44
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries:	44
Equity challenges in Indonesian health care	43
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled t	43
The landscape for rare diseases in 2024	43
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis	43
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data	43
Unveiling the crisis of the double burden of malnutrition	43
Homing in on haemoglobinopathies	42
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study	42
Can resistance testing improve outcomes for children and adolescents with HIV?	42
Correction to Lancet Glob Health 2024; 12: e1389–90	42
Donor aid and research funding for newborn babies and preventing stillbirths	40
Universal health coverage is fundamental to preparing for a healthier and better tomorrow	40
Can the ShangRing bring us closer to endorsing early infant male circumcision in sub-Saharan Africa?	39
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake	39
Tuberculosis and undernutrition in India – Authors’ reply	39
Innovative methods of determining health expenditure efficiency are urgently needed	39
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region	38
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries	38
Climate change and the right to health of people with disabilities	38
Avoiding another lost decade in reducing malaria burden in African infants and young children	38
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study	38
Quartile-based risk exposure in global IHD and ischaemic stroke	37
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study	37
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis	37
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines	36
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort	36
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories	36
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem	36
Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study	36
Wastewater monitoring can anchor global disease surveillance systems	36
The challenge of promoting physical activity in low-income and middle-income countries	36
Policy and service delivery proposals to improve primary care services in low-income and middle-income country cities	36
The role of digital health and artificial intelligence in improving the reach and effectiveness of HIV prevention in Africa	36

HIV testing during systematic screening for tuberculosis among household contacts in high-tuberculosis burden settings: a systematic review and meta-analysis	36
Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study	35
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries	35
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study	35
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort	35
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India	35
How the EAT–Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication	35
Nodding syndrome and doxycycline: promising findings with open questions	34
Targeting malaria control to schoolchildren	34
Relapse after recovery from acute malnutrition	34
The SARS-CoV2 pandemic and routine immunisation	34
Navigating AMR with innovative diagnostics	34
Aminoglycosides, deafness, and non-tuberculous mycobacteria	34
Postnatal morbidity: prevalent, enduring, and neglected	33
Prevention of pneumococcal diseases: the challenge remains	33
National diabetes prevention programmes in LMICs are now a necessity	33
Colorectal cancer screening with fecal immunochemical testing in Nigeria – Authors' reply	33
Colorectal cancer screening in sub-Saharan Africa	33
Pragmatic global health	32
Finding balance in Nigeria's mandatory health insurance	32
Trans Reform: an initiative for the recognition of transgender rights in a university in Lima, Peru	32
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial	32
Global variations in barriers to exercise for individuals with intellectual and developmental disability	32
Implementation science in Africa—whose epistemology counts?	32
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings	31
Correction to Lancet Glob Health 2025; 13: e528–84	31
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action	31
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial	31
The continuum of menstrual health through the life course	31
Correction to Lancet Glob Health 2025; 13: e309–18	31
Urgent call for the prioritisation of palliative care in Syria	31
Catastrophic health expenditure and chronic respiratory disease: evidence from Kenya	31
Mpox vaccination strategies in DR Congo	31
Balancing global access to opioids	31
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction – Authors' reply	30
Integrating mental health care to reduce intimate partner violence in complex humanitarian emergencies	30
Correction to Lancet Glob Health 2022; 10: 1715–43	30
Policy to progress: embedding enforcement in Asian NCCPs	30
Individual-level and community-level factors for 10-year cardiovascular disease risk in Ethiopia: a retrospective, population-based, cross-sectional, observational study	30
Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional s	29
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study	29
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study	29
Global, regional, and national causes of death in children and adolescents younger than 20 years: an open data portal with estimates for 2000–21	29
The need for a One Health approach for influenza surveillance	29
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study	29
The challenging road to universal health coverage	29
Defining the usefulness of oral swabs in tuberculosis diagnosis	29
The health toll of economic sanctions	28
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial	28
Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors	28
Neonatal mortality during the war in Tigray: a cross-sectional community-based study	28
Enabling access to quality abortion care: WHO's Abortion Care guideline	28
Combating antimicrobial resistance in neonatal infections: a South African perspective	28
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research	28
Enhancing cervical and breast cancer training in Africa with e-learning	27
Correction to Lancet Glob Health 2024; 12: e1209–13	27
Socioeconomic inequalities in palliative care access: insights from SHARE	27
Maximising the value of nudge units for global health	27
Clearing our heads over alcohol	27
Prediabetes: the best opportunity to reach remission	27
Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgame	27
Exposure to household air pollution from cooking fuel in Ugandan households and associated household factors: a retrospective analysis of demographic and health survey data	27
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study	27
Strengthening health-care systems to reduce child mortality	27
Evolving crises and unprecedented need: research on health in humanitarian settings must not be overlooked	27
Indigenous and minority groups in diabetes trials	27
Monitoring the benefits of human papillomavirus vaccination in low-income and middle-income countries	27
Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectiona	26
Short-term aid or long-term gains? Harnessing Sudan's humanitarian response for the resilience of its health system	26
Correction to Lancet Glob Health 2024; 12: e25–27	26
Obstetric fistula in Bangladesh: estimates from a national survey with clinical validation correction	26
Mind the gap: rethinking global alcohol metrics in high-abstention low-income and middle-income countries	26
Estimating dementia prevalence using remote diagnoses and algorithmic modelling: a population-based study of a rural region in South Africa	26
Mpox outbreaks in Africa constitute a public health emergency of continental security	26
Correction to Lancet Glob Health 2021; 9: e1610–17	26
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Mal	26
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care	26
Peripheral artery disease: a global need for detection, prevention, and treatment	26
What can we learn from developments in primary health care in south Asia?	25
The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice	25
The aetiology and prevalence of preoperative anaemia in patients undergoing major surgery (ALICE): an international, prospective, observational cohort study	25
COVID-19 vaccine hesitancy in Africa: a call to action	25
Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older	25
Bridging the divide between religion and health care	25
Redefining implementation science for global health decolonisation	25
Community interventions to prevent violence against women and girls in informal settlements in Mumbai: a theory-driven, pragmatic, cluster-randomised, controlled trial	25
Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators	25
Countries cannot cover the shortfall from US funding cuts	25
(Re-) considering success in implementation science: experiences amid a co-designed mHealth intervention in rural Uganda	25
Malaria guidelines fall short in diagnosing acute kidney injury	25
Measuring cause of death in rural southeast Asia	25
Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trial	25
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models	25
Nigeria's mandatory health insurance and the march towards universal health coverage	24
Democratising clinical trials research to strengthen primary health care	24